Drug Metabolism and Personalized Therapy Impact Factor in Pharmaceutics Journals

Drug Metabolism and Personalized Therapy in Pharmaceutics Journals

Journal Country: Germany
Journal Q tier: Q2
Publishing Firm: Walter de Gruyter GmbH
History: 2015-2022
Journal Homepage: ----
Journal ISSN: 23638907, 23638915

Research Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)

Impact Score: 1.05
h-Index: 37
SJR: 0.301
Ranking: 15087

About Drug Metabolism and Personalized Therapy

Drug Metabolism and Personalized Therapy is a journal covering the technologies/fields/categories related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3). It is published by Walter de Gruyter GmbH. The overall rank of Drug Metabolism and Personalized Therapy is 15087.According to SCImago Journal Rank (SJR), this journal is ranked 0.301. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 37. The best quartile for this journal is Q2.The ISSN of Drug Metabolism and Personalized Therapy journal is 23638907, 23638915.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Metabolism and Personalized Therapy is cited by a total of 213 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.